Atomoxetine (Strattera) and viloxazine (Qelbree) are both norepinephrine reuptake inhibitors that work by increasing norepinephrine in the prefrontal cortex, which secondarily increases dopamine and serotonin in that brain region.
factualpending
Speaker
Dr. Tracey MarksEvidence Quote
“Both medications are norepinephrine reuptake inhibitors, so they increase the amount of norepinephrine in the prefrontal cortex. This increased norepinephrine has a secondary effect of increasing dopamine and serotonin in this region of the brain.”
Created: 8/11/2026, 7:48:09 AM
Your notes
Loading notes...